3 hours Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Given Consensus Rating of “Moderate Buy” by Analysts MarketBeat
Shares of Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the five analysts that are currently covering the company, Marketbeat.com reports. Two research analysts have rated t…
Nasdaq 100 · Pharmaceuticals · Science